Lexpos News

/Lexpos News/

Flu Vaccination service: Provider Assurance activity begins

NHS England have announced, via their Primary Care Bulletin, that it will soon start to undertake provider assurance work with pharmacy owners providing the Flu Vaccination service. The reviews will engage with pharmacy owners who may have administered NHS flu vaccinations to adults outside of the announced and authorised cohorts prior to 3rd October 2024. [...]

The post Flu Vaccination service: Provider Assurance activity begins appeared first on Community Pharmacy England.

By |January 9th, 2025|Lexpos News|Comments Off on Flu Vaccination service: Provider Assurance activity begins

Medicine Supply Notification: Apomorphine hydrochloride (APO-go® PFS) 50mg/10ml solution for infusion pre-filled syringes

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Apomorphine hydrochloride (APO-go® PFS) 50mg/10ml solution for infusion pre-filled syringes. MSN/2025/002 Tier 2 – medium impact Date of issue: 9th January 2025 APO-go® (apomorphine hydrochloride) PFS are being discontinued; supplies are anticipated to be exhausted from early April 2025. APO-go® POD [...]

The post Medicine Supply Notification: Apomorphine hydrochloride (APO-go® PFS) 50mg/10ml solution for infusion pre-filled syringes appeared first on Community Pharmacy England.

By |January 9th, 2025|Lexpos News|Comments Off on Medicine Supply Notification: Apomorphine hydrochloride (APO-go® PFS) 50mg/10ml solution for infusion pre-filled syringes

MHRA Class 4 Medicines Defect Notification: Rabeprazole sodium 10mg and 20mg gastro-resistant tablets (Bristol Laboratories Limited)

MHRA Class 4 Medicines Defect Notification: Rabeprazole sodium 10mg and 20mg gastro-resistant tablets (Bristol Laboratories Limited) Drug alert number: EL (25)A/01 Date issued: 09 January 2025 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Rabeprazole sodium 10mg and 20mg gastro-resistant tablets (Bristol Laboratories Limited) DMRC [...]

The post MHRA Class 4 Medicines Defect Notification: Rabeprazole sodium 10mg and 20mg gastro-resistant tablets (Bristol Laboratories Limited) appeared first on Community Pharmacy England.

By |January 9th, 2025|Lexpos News|Comments Off on MHRA Class 4 Medicines Defect Notification: Rabeprazole sodium 10mg and 20mg gastro-resistant tablets (Bristol Laboratories Limited)

Updated: TriOn Pharma recalls Vitamin D3 2000iu/ml supplements because of excess levels of Vitamin D3

Update: (18/02/2025) : Point of sale notice added Date issued: 8 January 2025 TriOn Pharma is recalling two food supplement products. Aactive D3 Drops and Aactive D3 Solution because they contain higher levels of vitamin D3 than written on the label. Aactive D3 2,000iu/ml Oral Drops Batch No Expiry Date Pack Size LS23317 November 2025 [...]

The post Updated: TriOn Pharma recalls Vitamin D3 2000iu/ml supplements because of excess levels of Vitamin D3 appeared first on Community Pharmacy England.

By |January 9th, 2025|Lexpos News|Comments Off on Updated: TriOn Pharma recalls Vitamin D3 2000iu/ml supplements because of excess levels of Vitamin D3

MPs launch inquiry into medicine shortages

The All-Party Parliamentary Group (APPG) on Pharmacy has announced the launch of an inquiry into the impact of medicines shortages in England, the contributing factors and potential solutions. As part of this inquiry, the APPG has issued a call for written evidence from key stakeholders across the healthcare sector. This inquiry comes in response to [...]

The post MPs launch inquiry into medicine shortages appeared first on Community Pharmacy England.

By |January 8th, 2025|Lexpos News|Comments Off on MPs launch inquiry into medicine shortages